EU GMP Annex 1 and Parenteral Packaging: A Quality by Design Approach to Sterile Manufacturing

By Datwyler

Recent updates to the EU GMP Annex 1 have compelled pharmaceutical companies to focus on a Quality by Design approach to manufacturing and parenteral packaging, with a key focus on contamination control. In this whitepaper, you will learn about the implications of the new legislation and how to ensure compliance by sourcing packaging components that conform to the highest industry standards.

Enter your details below to view the free Whitepaper

By downloading this case study, you acknowledge that GlobalData may share your information with Datwyler and that your personal data will be used as described in their Privacy Policy

Visit our Privacy Policy for more information about our services, how GlobalData may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.